MSD inaugurates new 30M -euro filling and packaging facilities for Gardasil

Merck Sharp & Dohme, the UK subsidiary of US drug major Merck & Co, has inaugurated new 30.0-million-euro ($38.3 million), state-of-the-art filling and packaging facilities for its human papillomavirus vaccine Gardasil, at its production plant in Haarlem, the Netherlands. All filling and packaging of Gardasil for Europe will now be performed at the facility. This adds to a 200.0-million-euro investment in a new strategic vaccine production site in Carlow, Ireland, made earlier this year.